Hua Haiqing

Hua Haiqing (chief executive) discloses dealings in Duality Biotherapeutics, Inc. - B to HKEX. We count 5 filings; the first trade dates from 23 March 2026 and the latest from 29 September 2026.

No open-market purchase appears, only 2 sales worth €2.2M.

The newest entry dates from 2 October 2026: an open-market sale of €878k, in Duality Biotherapeutics, Inc. - B. Between a trade and the moment it shows up on HKEX, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from HKEX disclosures alone and does not predict where the share price will go.